Stephen James Read
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Stephen James Read has a total of 214 co-authors. Here are the top co-authors by number of shared publications:
- Geoffrey Alan Donnan
Melbourne Brain Centre, Royal Melbourne Hospital, University of Melbourne, Victoria, Australia (G.A.D.).
19 shared publications - Andrew Wong
Department of Neurology, Royal Brisbane and Women's Hospital, Herston, Australia
16 shared publications Robert D. Henderson
Department of Neurology, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia; School of Medicine, The University of Queensland, Brisbane, QLD, Australia
11 shared publications- John D. O'SUllivan
UQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Herston, Australia
9 shared publications Linda Worrall
Communication Disability Centre and the CCRE in Aphasia Rehabilitation, School of Health and Rehabilitation Sciences, The University of Queensland, St Lucia, Queensland, Australia
7 shared publications- Pamela Ann McCombe
University of Queensland
7 shared publications
Latest Publications
- 1 August 2019
- Published by Elsevier in Brain and Language
- Vol. 195, 104630
Brain activity during spoken word recognition in subacute aphasia
- 1 August 2019
- Published by Elsevier in Brain and Language
- Vol. 195, 104630
Brain activity during spoken word recognition in subacute aphasia
- 7 November 2016
- Published by Wiley in Psychophysiology
- Vol. 54 (2) , 301-309
Poststroke QEEG informs early prognostication of cognitive impairment
Cognitive impairment is a common consequence of stroke, but remains difficult to predict. We investigate the ability of early QEEG assessment to inform such prediction, using binary logistic regression. Thirty‐five patients (12 female, ages 18–87) suffering middle cerebral artery, ischemic stroke were studied. Resting‐state EEG was recorded 48–239 h after symptom onset. Relative power for delta, theta, alpha, and beta bands, delta:alpha ratio, and peak alpha frequency were analyzed. Montreal Cognitive Assessment (MoCA) was administered, where possible, on day of EEG and at median 99 days (range 69–138) poststroke. Eight patients could not complete the baseline MoCA, and four the follow‐up MoCA, for varying reasons (most commonly, stroke symptoms). Fifteen patients (48%) had cognitive impairment (MoCA score ≤25) at follow‐up. One QEEG index was able to correctly predict presence/absence of cognitive impairment in 24/31 patients (77.4%), whereas predischarge MoCA did so in 23 patients. This index, relative theta frequency (4–7.5 Hz) power, was computed from only three posterior electrodes over the stroke‐affected hemisphere. Its predictive accuracy (three electrodes) was higher than that of any “global” QEEG measure (averaged over 19 electrodes). These results may signify association between poststroke alpha slowing and cognitive impairment, which may be mediated by attentional (dys)function, which warrants further investigation. Pending further studies, QEEG measure(s)—from a few electrodes—could inform early prognostication of poststroke cognitive outcomes (and clinical decisions), particularly when cognitive function cannot be adequately assessed (due to symptoms, language, or other issues) or when assessment is equivocal.
- 7 November 2016
- Published by Wiley in Psychophysiology
- Vol. 54 (2) , 301-309
Poststroke QEEG informs early prognostication of cognitive impairment
Cognitive impairment is a common consequence of stroke, but remains difficult to predict. We investigate the ability of early QEEG assessment to inform such prediction, using binary logistic regression. Thirty‐five patients (12 female, ages 18–87) suffering middle cerebral artery, ischemic stroke were studied. Resting‐state EEG was recorded 48–239 h after symptom onset. Relative power for delta, theta, alpha, and beta bands, delta:alpha ratio, and peak alpha frequency were analyzed. Montreal Cognitive Assessment (MoCA) was administered, where possible, on day of EEG and at median 99 days (range 69–138) poststroke. Eight patients could not complete the baseline MoCA, and four the follow‐up MoCA, for varying reasons (most commonly, stroke symptoms). Fifteen patients (48%) had cognitive impairment (MoCA score ≤25) at follow‐up. One QEEG index was able to correctly predict presence/absence of cognitive impairment in 24/31 patients (77.4%), whereas predischarge MoCA did so in 23 patients. This index, relative theta frequency (4–7.5 Hz) power, was computed from only three posterior electrodes over the stroke‐affected hemisphere. Its predictive accuracy (three electrodes) was higher than that of any “global” QEEG measure (averaged over 19 electrodes). These results may signify association between poststroke alpha slowing and cognitive impairment, which may be mediated by attentional (dys)function, which warrants further investigation. Pending further studies, QEEG measure(s)—from a few electrodes—could inform early prognostication of poststroke cognitive outcomes (and clinical decisions), particularly when cognitive function cannot be adequately assessed (due to symptoms, language, or other issues) or when assessment is equivocal.
- Top Cited Papers
- 1 February 2016
- Published by Elsevier in Clinical Neurophysiology
- Vol. 127 (2) , 1452-1459
Defining abnormal slow EEG activity in acute ischaemic stroke: Delta/alpha ratio as an optimal QEEG index
- 1 February 2016
- Published by Elsevier in Clinical Neurophysiology
- Vol. 127 (2) , 1452-1459
Top Cited PapersDefining abnormal slow EEG activity in acute ischaemic stroke: Delta/alpha ratio as an optimal QEEG index
- 1 November 2014
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 21 (11) , 2028-2030
Vertebrobasilar dissections: Case series comparing patients with and without dissecting aneurysms
- 1 November 2014
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 21 (11) , 2028-2030
Vertebrobasilar dissections: Case series comparing patients with and without dissecting aneurysms
- 1 October 2014
- Published by Elsevier in International Journal of Psychophysiology
- Vol. 94 (1) , 19-24
Frontal EEG delta/alpha ratio and screening for post-stroke cognitive deficits: The power of four electrodes
- 1 October 2014
- Published by Elsevier in International Journal of Psychophysiology
- Vol. 94 (1) , 19-24
Frontal EEG delta/alpha ratio and screening for post-stroke cognitive deficits: The power of four electrodes
- 22 January 2014
- Published by Wiley in Human Brain Mapping
- Vol. 35 (8) , 3919-3931
A functional MRI study of the relationship between naming treatment outcomes and resting state functional connectivity in post‐stroke aphasia
Background: The majority of studies investigating the neural mechanisms underlying treatment in people with aphasia have examined task‐based brain activity. However, the use of resting‐state fMRI may provide another method of examining the brain mechanisms responsible for treatment‐induced recovery, and allows for investigation into connectivity within complex functional networksMethods: Eight people with aphasia underwent 12 treatment sessions that aimed to improve object naming. Half the sessions employed a phonologically‐based task, and half the sessions employed a semantic‐based task, with resting‐state fMRI conducted pre‐ and post‐treatment. Brain regions in which the amplitude of low frequency fluctuations (ALFF) correlated with treatment outcomes were used as seeds for functional connectivity (FC) analysis. FC maps were compared from pre‐ to post‐treatment, as well as with a group of 12 healthy older controlsResults: Pre‐treatment ALFF in the right middle temporal gyrus (MTG) correlated with greater outcomes for the phonological treatment, with a shift to the left MTG and supramarginal gyrus, as well as the right inferior frontal gyrus, post‐treatment. When compared to controls, participants with aphasia showed both normalization and up‐regulation of connectivity within language networks post‐treatment, predominantly in the left hemisphereConclusions: The results provide preliminary evidence that treatments for naming impairments affect the FC of language networks, and may aid in understanding the neural mechanisms underlying the rehabilitation of language post‐stroke. Hum Brain Mapp 35:3919–3931, 2014. © 2014 Wiley Periodicals, Inc.
- 22 January 2014
- Published by Wiley in Human Brain Mapping
- Vol. 35 (8) , 3919-3931
A functional MRI study of the relationship between naming treatment outcomes and resting state functional connectivity in post‐stroke aphasia
Background: The majority of studies investigating the neural mechanisms underlying treatment in people with aphasia have examined task‐based brain activity. However, the use of resting‐state fMRI may provide another method of examining the brain mechanisms responsible for treatment‐induced recovery, and allows for investigation into connectivity within complex functional networksMethods: Eight people with aphasia underwent 12 treatment sessions that aimed to improve object naming. Half the sessions employed a phonologically‐based task, and half the sessions employed a semantic‐based task, with resting‐state fMRI conducted pre‐ and post‐treatment. Brain regions in which the amplitude of low frequency fluctuations (ALFF) correlated with treatment outcomes were used as seeds for functional connectivity (FC) analysis. FC maps were compared from pre‐ to post‐treatment, as well as with a group of 12 healthy older controlsResults: Pre‐treatment ALFF in the right middle temporal gyrus (MTG) correlated with greater outcomes for the phonological treatment, with a shift to the left MTG and supramarginal gyrus, as well as the right inferior frontal gyrus, post‐treatment. When compared to controls, participants with aphasia showed both normalization and up‐regulation of connectivity within language networks post‐treatment, predominantly in the left hemisphereConclusions: The results provide preliminary evidence that treatments for naming impairments affect the FC of language networks, and may aid in understanding the neural mechanisms underlying the rehabilitation of language post‐stroke. Hum Brain Mapp 35:3919–3931, 2014. © 2014 Wiley Periodicals, Inc.
- 2 December 2013
- Published by SAGE Publications in Neurorehabilitation and Neural Repair
- Vol. 28 (4) , 325-334
Changes in White Matter Connectivity Following Therapy for Anomia Post stroke
Background. The majority of studies investigating the neural mechanisms underlying treatment-induced recovery in aphasia have focused on the cortical regions associated with language processing. However, the integrity of the white matter connecting these regions may also be crucial to understanding treatment mechanisms. Objective. This study investigated the integrity of the arcuate fasciculus (AF) and uncinate fasciculus (UF) before and after treatment for anomia in people with aphasia. Method. Eight people with aphasia received 12 treatment sessions to improve naming; alternating between phonologically-based and semantic-based tasks, with high angular resolution diffusion imaging conducted pre and post treatment. The mean generalized fractional anisotropy (GFA), a measure of fiber integrity, and number of fibers in the AF and UF were compared pre and post treatment, as well as with a group of 14 healthy older controls. Results. Pre treatment, participants with aphasia had significantly fewer fibers and lower mean GFA in the left AF compared with controls. Post treatment, mean GFA increased in the left AF to be statistically equivalent to controls. Additionally, mean GFA in the left AF pre and post treatment positively correlated with maintenance of the phonologically based treatment. No differences were found in the right AF, or the UF in either hemisphere, between participants with aphasia and controls, and no changes were observed in these tracts following treatment. Conclusions. Anomia treatments may improve the integrity of the white matter connecting cortical language regions. These preliminary results add to the understanding of the mechanisms underlying treatment outcomes in people with aphasia post stroke.
- 2 December 2013
- Published by SAGE Publications in Neurorehabilitation and Neural Repair
- Vol. 28 (4) , 325-334
Changes in White Matter Connectivity Following Therapy for Anomia Post stroke
Background. The majority of studies investigating the neural mechanisms underlying treatment-induced recovery in aphasia have focused on the cortical regions associated with language processing. However, the integrity of the white matter connecting these regions may also be crucial to understanding treatment mechanisms. Objective. This study investigated the integrity of the arcuate fasciculus (AF) and uncinate fasciculus (UF) before and after treatment for anomia in people with aphasia. Method. Eight people with aphasia received 12 treatment sessions to improve naming; alternating between phonologically-based and semantic-based tasks, with high angular resolution diffusion imaging conducted pre and post treatment. The mean generalized fractional anisotropy (GFA), a measure of fiber integrity, and number of fibers in the AF and UF were compared pre and post treatment, as well as with a group of 14 healthy older controls. Results. Pre treatment, participants with aphasia had significantly fewer fibers and lower mean GFA in the left AF compared with controls. Post treatment, mean GFA increased in the left AF to be statistically equivalent to controls. Additionally, mean GFA in the left AF pre and post treatment positively correlated with maintenance of the phonologically based treatment. No differences were found in the right AF, or the UF in either hemisphere, between participants with aphasia and controls, and no changes were observed in these tracts following treatment. Conclusions. Anomia treatments may improve the integrity of the white matter connecting cortical language regions. These preliminary results add to the understanding of the mechanisms underlying treatment outcomes in people with aphasia post stroke.
- 10 November 2013
- Published by SAGE Publications in International Journal of Stroke
- Vol. 10 (4) , 636-644
STroke imAging pRevention and Treatment (START): A Longitudinal Stroke Cohort Study: Clinical Trials Protocol
Rationale: Stroke and poststroke depression are common and have a profound and ongoing impact on an individual's quality of life. However, reliable biological correlates of poststroke depression and functional outcome have not been well established in humans. Aims: Our aim is to identify biological factors, molecular and imaging, associated with poststroke depression and recovery that may be used to guide more targeted interventions. Design: In a longitudinal cohort study of 200 stroke survivors, the START – STroke imAging pRevention and Treatment cohort, we will examine the relationship between gene expression, regulator proteins, depression, and functional outcome. Stroke survivors will be investigated at baseline, 24 h, three-days, three-months, and 12 months poststroke for blood-based biological associates and at days 3–7, three-months, and 12 months for depression and functional outcomes. A sub-group ( n = 100), the PrePARE: Prediction and Prevention to Achieve optimal Recovery Endpoints after stroke cohort, will also be investigated for functional and structural changes in putative depression-related brain networks and for additional cognition and activity participation outcomes. Stroke severity, diet, and lifestyle factors that may influence depression will be monitored. The impact of depression on stroke outcomes and participation in previous life activities will be quantified. Study Outcomes: Clinical significance lies in the identification of biological factors associated with functional outcome to guide prevention and inform personalized and targeted treatments. Evidence of associations between depression, gene expression and regulator proteins, functional and structural brain changes, lifestyle and functional outcome will provide new insights for mechanism-based models of poststroke depression.
- 10 November 2013
- Published by SAGE Publications in International Journal of Stroke
- Vol. 10 (4) , 636-644
STroke imAging pRevention and Treatment (START): A Longitudinal Stroke Cohort Study: Clinical Trials Protocol
Rationale: Stroke and poststroke depression are common and have a profound and ongoing impact on an individual's quality of life. However, reliable biological correlates of poststroke depression and functional outcome have not been well established in humans. Aims: Our aim is to identify biological factors, molecular and imaging, associated with poststroke depression and recovery that may be used to guide more targeted interventions. Design: In a longitudinal cohort study of 200 stroke survivors, the START – STroke imAging pRevention and Treatment cohort, we will examine the relationship between gene expression, regulator proteins, depression, and functional outcome. Stroke survivors will be investigated at baseline, 24 h, three-days, three-months, and 12 months poststroke for blood-based biological associates and at days 3–7, three-months, and 12 months for depression and functional outcomes. A sub-group ( n = 100), the PrePARE: Prediction and Prevention to Achieve optimal Recovery Endpoints after stroke cohort, will also be investigated for functional and structural changes in putative depression-related brain networks and for additional cognition and activity participation outcomes. Stroke severity, diet, and lifestyle factors that may influence depression will be monitored. The impact of depression on stroke outcomes and participation in previous life activities will be quantified. Study Outcomes: Clinical significance lies in the identification of biological factors associated with functional outcome to guide prevention and inform personalized and targeted treatments. Evidence of associations between depression, gene expression and regulator proteins, functional and structural brain changes, lifestyle and functional outcome will provide new insights for mechanism-based models of poststroke depression.
- 12 September 2013
- Published by Taylor & Francis in International Journal of Neuroscience
- Vol. 124 (4) , 271-280
Correlation of Adrenomedullin gene expression in peripheral blood leukocytes with severity of ischemic stroke
Human adrenomedullin (ADM), a 52-amino acid peptide, belongs to the calcitonin/calcitonin gene-related peptide (CGRP)/amylin peptide family. ADM acts as a multifunctional regulatory peptide and is upregulated in response to hypoxia. Previous microarray studies have found increased ADM gene (ADM) expression in peripheral blood cells of patients with stroke, however, it is unknown if an increased ADM level is correlated with severity of human ischemic stroke. This study investigated ADM expression in peripheral blood leukocytes (PBL) of healthy controls and subjects at day 1, week 1 and week 3 postacute ischemic stroke using rtPCR methodology. We found that ADM expression was significantly upregulated on the first day of stroke compared to the healthy subjects and the disease controls; the levels remained elevated for up to week 3. Further, ADM expression at day 1 was correlated with stroke severity measured by the National Institute of Healthy Stroke Scale (NIHSS), the modified Barthel Index (mBI) and the modified Rankin Scale (mRS). This could indicate that ADM expression level is related to the severity of tissue damage. We suggest that increased ADM expression in PBL after acute ischemic stroke is most likely to indicate that these cells have been subjected to hypoxia and that the magnitude of expression is likely to be related to the volume of hypoxic tissue. Hypoxia can affect lymphocytes function and could affect the immune response to stroke. The correlation of ADM expression level with the measures of stroke severity implicates ADM--a potential blood bio-marker in studies of ischemic stroke.
- 12 September 2013
- Published by Taylor & Francis in International Journal of Neuroscience
- Vol. 124 (4) , 271-280
Correlation of Adrenomedullin gene expression in peripheral blood leukocytes with severity of ischemic stroke
Human adrenomedullin (ADM), a 52-amino acid peptide, belongs to the calcitonin/calcitonin gene-related peptide (CGRP)/amylin peptide family. ADM acts as a multifunctional regulatory peptide and is upregulated in response to hypoxia. Previous microarray studies have found increased ADM gene (ADM) expression in peripheral blood cells of patients with stroke, however, it is unknown if an increased ADM level is correlated with severity of human ischemic stroke. This study investigated ADM expression in peripheral blood leukocytes (PBL) of healthy controls and subjects at day 1, week 1 and week 3 postacute ischemic stroke using rtPCR methodology. We found that ADM expression was significantly upregulated on the first day of stroke compared to the healthy subjects and the disease controls; the levels remained elevated for up to week 3. Further, ADM expression at day 1 was correlated with stroke severity measured by the National Institute of Healthy Stroke Scale (NIHSS), the modified Barthel Index (mBI) and the modified Rankin Scale (mRS). This could indicate that ADM expression level is related to the severity of tissue damage. We suggest that increased ADM expression in PBL after acute ischemic stroke is most likely to indicate that these cells have been subjected to hypoxia and that the magnitude of expression is likely to be related to the volume of hypoxic tissue. Hypoxia can affect lymphocytes function and could affect the immune response to stroke. The correlation of ADM expression level with the measures of stroke severity implicates ADM--a potential blood bio-marker in studies of ischemic stroke.
- 1 September 2013
- Published by Elsevier in Clinical Neurophysiology
- Vol. 124 (9) , 1913-1914
QEEG may uniquely inform and expedite decisions regarding intra-arterial clot retrieval in acute stroke
- 1 September 2013
- Published by Elsevier in Clinical Neurophysiology
- Vol. 124 (9) , 1913-1914
QEEG may uniquely inform and expedite decisions regarding intra-arterial clot retrieval in acute stroke